Skip to main navigation Skip to search Skip to main content

Corylin attenuates oral squamous cell carcinoma progression through c-Myc inhibition

  • Chin Chuan Chen
  • , Chi Yuan Chen
  • , Li Fang Chou
  • , Chau Ting Yeh
  • , Yi Tsen Liu
  • , Yu De Chu
  • , Hsin Wei Lin
  • , Kai Yin Chen
  • , Cheng Chia Yu*
  • , Tong Hong Wang*
  • *Corresponding author for this work
  • Chang Gung Memorial Hospital
  • Chang Gung University of Science and Technology
  • Chung Shan Medical University
  • Chang Gung University

Research output: Contribution to journal › Journal Article › peer-review

4 Scopus citations

Abstract

Background: /purpose: Oral squamous cell carcinoma (OSCC) is the most prevalent malignancy of the head and neck, with current treatment options often limited by low efficacy and drug resistance. In this study, we investigated the anticancer activity and underlying mechanisms of corylin, a flavonoid extracted from Psoralea corylifolia, in OSCC. Materials and methods: OSCC cell lines (SAS and OECM1) were treated with corylin, and its effects on cell proliferation, migration, and invasion were assessed using cell function assays. Flow cytometry and DiOC6/PI staining were performed to analyze cell cycle progression and apoptosis, while Western blotting was used to elucidate the molecular mechanisms of corylin's action. Results: Corylin selectively inhibited OSCC cell growth, migration, and invasion while exhibiting minimal toxicity toward normal human cells. Mechanistic investigations revealed that corylin downregulated c-Myc expression, which subsequently modulated the expression of cell cycle checkpoint regulators, apoptosis-related proteins, and epithelial–mesenchymal transition (EMT)-associated markers. This led to G1 phase cell cycle arrest and enhanced apoptosis induction. Additionally, corylin significantly enhanced the anticancer efficacy of cisplatin and 5-FU in OSCC cells. Conclusion: Corylin exhibits potent anticancer activity against OSCC by targeting c-Myc-mediated oncogenic pathways and may serve as a promising therapeutic candidate. Furthermore, its ability to synergize with cisplatin and 5-FU suggests its potential role in combination therapy to improve treatment efficacy.

Original languageEnglish
Pages (from-to)2322-2331
Number of pages10
JournalJournal of Dental Sciences
Volume20
Issue number4
DOIs
StatePublished - 10 2025

Bibliographical note

© 2025 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier B.Vé.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Combination therapy
  • Corylin
  • Epithelial–mesenchymal transition (EMT)
  • Oral squamous cell carcinoma (OSCC)
  • c-Myc

Fingerprint

Dive into the research topics of 'Corylin attenuates oral squamous cell carcinoma progression through c-Myc inhibition'. Together they form a unique fingerprint.

Cite this